Education
About Us
Working with TipRanks
Follow Us
IRLAB Therapeutics AB Class A (DE:6IRA)
FRANKFURT:6IRA
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | kr 57.46M | kr 94.63M | kr 5.68M | kr 61.14M | kr 207.78M |
| Gross Profit | kr -92.35M | kr -92.42M | kr -122.73M | kr -111.23M | kr 168.69M |
| Operating Income | kr -92.35M | kr -75.11M | kr -180.76M | kr -113.11M | kr 52.58M |
| EBITDA | kr -88.03M | kr -68.07M | kr -173.32M | kr -109.13M | kr 55.79M |
| Net Income | kr -110.01M | kr -83.13M | kr -177.84M | kr -114.20M | kr 51.78M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | kr 81.86M | kr 66.92M | kr 111.31M | kr 252.78M | kr 401.90M |
| Total Assets | kr 138.21M | kr 136.21M | kr 177.12M | kr 323.56M | kr 472.45M |
| Total Debt | kr 29.95M | kr 60.42M | kr 27.57M | kr 3.98M | kr 6.60M |
| Net Debt | kr -51.91M | kr -6.50M | kr -83.74M | kr -248.80M | kr -395.30M |
| Total Liabilities | kr 107.49M | kr 103.58M | kr 61.36M | kr 32.72M | kr 72.97M |
| Stockholders' Equity | kr 30.72M | kr 32.63M | kr 115.76M | kr 290.83M | kr 399.48M |
| Cash Flow | |||||
| Free Cash Flow | kr -55.22M | kr -65.79M | kr -165.14M | kr -145.99M | kr 127.93M |
| Operating Cash Flow | kr -55.22M | kr -65.59M | kr -164.85M | kr -142.61M | kr 128.64M |
| Investing Cash Flow | kr 0.00 | kr -199.00K | kr -293.00K | kr -3.38M | kr -708.00K |
| Financing Cash Flow | kr 73.41M | kr 21.40M | kr 23.68M | kr -3.13M | kr -3.04M |